Actions

Summary tables comparing neoplastic disorders: Difference between revisions

From haematologyetc.co.uk

No edit summary
Tag: Manual revert
No edit summary
Line 55: Line 55:
|-
|-
|colspan="1" style = "font-size:90%; color:black;" |CD38
|colspan="1" style = "font-size:90%; color:black;" |CD38
|colspan="1" style = "background:#66e0ff;"|
|colspan="1" style = "background:#66e0ff;color:black; font-size:80%"|20:40
|colspan="1" style = "background:#004466;"|
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80
|-
|-
|colspan="1" style = "font-size:90%;" |CD43
|colspan="1" style = "font-size:90%;" |CD43

Revision as of 21:48, 21 June 2023

Immunophenotype LPD
Marker CLL MCL FL
κ/λ 40:80 wk >80 40:80
FMC7 20:40 wk 40:80 40:80
CD5 >80 >80 longer <5%
CD10 5-20 5-20 >80 Stg
CD11C 20:40 wk 20:40 wk <5%
CD19 >80 >80 40:80
CD20 >80 >80 >80
CD23 >80 5-20 40:80
CD25 20:40 wk 20:40 wk 5-20 wk
CD38 20:40 >80 >80
CD43
CD79a wk
CD103
CD138
CD200

Key to table:


Key to colour code Click for link

Key to expression code Click for link